Imaging approaches to patients with polycystic kidney disease

Seminars in Nephrology

Volumn 31, Issue 3, 2011, Pages 237-244

  Chapman, Arlene B ^a   Wei, Wenjing ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney volume; MRI; Polycystic kidney disease

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GLOMERULUS FILTRATION RATE; HUMAN; IMAGE ANALYSIS; KIDNEY BLOOD FLOW; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT MONITORING; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; POLYCYSTIC KIDNEY DISEASES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960616517     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.05.003     Document Type: Article

References (34)

1. Bae K.T., Grantham J.J. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2010, 6:96-106.
2. Grantham J.J. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008, 359:1477-1485.
3. Harris P.C., Torres V.E. Polycystic kidney disease. Annu Rev Med 2009, 60:321-337.
4. Ravine D., Gibson R.N., Walker R.G., et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994, 343:824-827.
5. Nicolau C., Torra R., Badenas C., et al. Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 1999, 213:273-276.
6. Pei Y., Obaji J., Dupuis A., et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2009, 20:205-212.
7. Wołyniec W., Jankowska M.M., Król E., et al. Current diagnostic evaluation of autosomal dominant polycystic kidney disease. Pol Arch Med Wewn 2008, 118:767-773.
8. Gabow P.A., Kimberling W.J., Strain J.D., et al. Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 1997, 8:105-110.
9. Nascimento A.B., Mitchell D.G., Zhang X.M., et al. Rapid MR imaging detection of renal cysts: age-based standards. Radiology 2001, 221:628-632.
10. Bakker J., Olree M., Kaatee R., et al. Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology 1999, 211:623-628.
11. Bakker J., Olree M., Kaatee R., et al. In vitro measurement of kidney size: comparison of ultrasonography and MRI. Ultrasound Med Biol 1998, 24:683-688.
12. Fick-Brosnahan G.M., Belz M.M., McFann K.K., et al. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis 2002, 39:1127-1134.
13. O'Neill W.C., Robbin M.L., Bae K.T., et al. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am J Kidney Dis 2005, 46:1058-1064.
14. Thomsen H.S., Madsen J.K., Thaysen J.H., Damgaard-Petersen K. Volume of polycystic kidneys during reduction of renal function. Urol Radiol 1981, 3:85-89.
15. Sise C., Kusaka M., Wetzel L.H., et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int 2000, 58:2492-2501.
16. Chapman A.B., Guay-Woodford L.M., Grantham J.J., et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 2003, 64:1035-1045.
17. Fick-Brosnahan G., Johnson A.M., Strain J.D., Gabow P.A. Renal asymmetry in children with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999, 34:639-645.
18. Fick-Brosnahan G.M., Tran Z.V., Johnson A.M., Strain J.D., Gabow P.A. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 2001, 59:1654-1662.
19. King B.F., Reed J.E., Bergstralh E.J., Sheedy P.F., Torres V.E. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchymal volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2000, 11:1505-1511.
20. Ruggenenti P., Remuzzi A., Ondei P., et al. Safety and efficacy of long-acting somatostatin treatment in autosomal dominant polycystic kidney disease. Kidney Int 2005, 68:206-216.
21. Harris P.C., Bae K.T., Rossetti S., et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2006, 17:3013-3019.
22. Bae K.T., Zhu F., Chapman A.B., et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. Clin J Am Soc Nephrol 2006, 1:64-69. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
23. Chapman A.B. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol 2008, 3:1197-1204.
24. Chapman A.B., Johnson A., Gabow P.A., Schrier R.W. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990, 323:1091-1096.
25. Watson M.L., Macnicol A.M., Allan P.L., Wright A.F. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 1992, 41:206-210.
26. Berg U.B. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 2006, 21:2577-2582.
27. Dambreville S., Chapman A.B., Torres V.E., et al. Renal arterial blood flow measurement by breath-held MRI: accuracy in phantom scans and reproducibility in healthy subjects. Magn Reson Med 2010, 63:940-950.
28. King B.F., Torres V.E., Brummer M.E., et al. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod 2005, 11:65-71.
29. King B.F., Torres V.E., Brummer M.E., et al. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int 2003, 64:2214-2221.
30. Torres V.E., King B.F., Chapman A.B., et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007, 2:112-120.
31. Antiga L., Piccinelli M., Fasolini G., et al. Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report. Clin J Am Soc Nephrol 2006, 1:754-760.
32. Ruggenenti P., Remuzzi A., Patriziaondel E., et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 2005, 68:206-216.
33. O'Neill W.C. Atlas of renal ultrasonography 2006, 94-95. Margonos Productions, Decatur.
34. Marotti M., Hricak H., Fritzsche P., et al. Complex and simple renal cysts: comparative evaluation with MR imaging. Radiology 1987, 162:679-684.